Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly,
collaborative efforts between national and international organizations and the …

Objectives This study aimed to compare the efficacy and safety of combination therapy with
high-dose sulbactam or colistin with additional antibacterial agents for treating multidrug …

This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

Abstract Background Differentiating Acinetobacter baumannii complex (ABC) infection from
colonization remains difficult and further complicated in polymicrobial infections. Purpose To …

Multidrug-resistant (MDR) Acinetobacter baumannii presents a critical challenge to human
health worldwide and polymyxins are increasingly used as a last-line therapy. Due to the …

Objectives The optimal treatment option for carbapenem-resistant Acinetobacter baumannii
(CRAB) is still limited. This study investigated the efficacy of three or more antibiotic types …

Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant
Infections: A Systematic Review and Meta-analysis - PMC Back to Top Skip to main content NIH …

The discovery of penicillin over 90 years ago and its subsequent uptake by healthcare
systems around the world revolutionised global health. It marked the beginning of a golden …

The article presents a literature review on the current aspects of antibacterial drug
administration when treating nosocomial pneumonia. Current data are presented regarding …

Over the years, peptides have evolved as viable drug leads in research & development for
different biomedical applications. The importance of developing peptides as potent …